{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T11:22:13Z","timestamp":1793532133150,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Danish Regions Medical Fund"},{"DOI":"10.13039\/100008392","name":"Sundhed og Sygdom, Det Frie Forskningsr\u00e5d","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-27988-6","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T01:55:37Z","timestamp":1767750937000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Plasma growth differentiation factor-15 is associated with cardiovascular events in patients hospitalized for acute exacerbation of COPD"],"prefix":"10.1038","volume":"16","author":[{"given":"Pradeesh","family":"Sivapalan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Alexander","family":"Ackermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Kubel","family":"Vognsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Frikke-Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens P.","family":"Goetze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Th\u00e9r\u00e8se","family":"Lappere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Christoffersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon Torgny","family":"Wilcke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte S.","family":"Ulrik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas Dyrby","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mats C. H\u00f8jbjerg","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander G.","family":"Mathioudakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f8rgen","family":"Vestbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manan","family":"Pareek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tor","family":"Biering-S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens-Ulrik","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"key":"27988_CR1","doi-asserted-by":"crossref","unstructured":"Hurst, J.R., Gale, C.P., Hurst, J.R., Bhutani M, Bourbeau J, Han ML, et al. MACE in COPD: addressing cardiopulmonary risk. Lancet Respir. Med. 12(5):345\u20138. https:\/\/www.thelancet.com\/action\/showFullText?pii=S2213260024000389. (2024).","DOI":"10.1016\/S2213-2600(24)00038-9"},{"key":"27988_CR2","doi-asserted-by":"crossref","unstructured":"Mkorombindo, T., Dransfield, M.T. COPD exacerbations and MACE: More than a chance encounter?. Respirology. 24 (12):1129\u201330. https:\/\/pubmed.ncbi.nlm.nih.gov\/31432595\/. (2019).","DOI":"10.1111\/resp.13683"},{"key":"27988_CR3","doi-asserted-by":"crossref","unstructured":"S\u00e1-Sousa, A., Rodrigues, C., J\u00e1come, C., Cardoso, J., Fortuna, I., Guimar\u00e3es, M. et al. Cardiovascular risk in patients with chronic obstructive pulmonary disease: a systematic Review. J. Clin. Med. 13 (17). https:\/\/pubmed.ncbi.nlm.nih.gov\/39274386\/. (2024).","DOI":"10.3390\/jcm13175173"},{"key":"27988_CR4","doi-asserted-by":"crossref","unstructured":"Sin, D.D., Anthonisen, N.R., Soriano, J.B., Agusti, A.G. Mortality in COPD: Role of comorbidities. Eur. Respir. J. 28(6):1245\u201357. https:\/\/pubmed.ncbi.nlm.nih.gov\/17138679\/. (2006).","DOI":"10.1183\/09031936.00133805"},{"issue":"12","key":"27988_CR5","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1111\/resp.13620","volume":"24","author":"M Reilev","year":"2019","unstructured":"Reilev, M. et al. Increased risk of major adverse cardiac events following the onset of acute exacerbations of COPD. Respirology 24(12), 1183\u20131190. https:\/\/doi.org\/10.1111\/resp.13620 (2019).","journal-title":"Respirology"},{"key":"27988_CR6","doi-asserted-by":"crossref","unstructured":"Pirera, E., Di Raimondo, D., D\u2019Anna, L., Tuttolomondo, A. Risk trajectory of cardiovascular events after an exacerbation of chronic obstructive pulmonary disease: A systematic review and meta-analysis. Eur. J. Intern. Med. (2025).","DOI":"10.1016\/j.ejim.2025.01.016"},{"key":"27988_CR7","doi-asserted-by":"crossref","unstructured":"Li, D., Wu, Y., Guo, S., Qin, J., Feng, M., An, Y. et al. Circulating syndecan-1 as a novel biomarker relates to lung function, systemic inflammation, and exacerbation in COPD. Int. J. Chron. Obstruct Pulmon Dis. 14 :1933\u201341. https:\/\/pubmed.ncbi.nlm.nih.gov\/31695352\/. (2019).","DOI":"10.2147\/COPD.S207855"},{"key":"27988_CR8","doi-asserted-by":"crossref","unstructured":"Wernly, B., Fuernau, G., Masyuk, M., Muessig, J.M., Pfeiler, S., Bruno R.R. et al. Syndecan-1 predicts outcome in patients with ST-segment elevation infarction independent from infarct-related myocardial injury. Sci. Rep.\u00a09(1): 1\u20137. https:\/\/www.nature.com\/articles\/s41598-019-54937-x. (2019).","DOI":"10.1038\/s41598-019-54937-x"},{"key":"27988_CR9","doi-asserted-by":"crossref","unstructured":"Kato, E.T., Morrow, D.A., Guo, J., Berg, D.D., Blazing, M.A., Bohula, E.A. et al. Growth differentiation factor 15 and cardiovascular risk: individual patient meta-analysis. Eur. Heart J. 44 (4):293\u2013300. https:\/\/pubmed.ncbi.nlm.nih.gov\/36303404\/. (2023).","DOI":"10.1093\/eurheartj\/ehac577"},{"issue":"7","key":"27988_CR10","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1007\/s11239-024-03019-5","volume":"57","author":"L Lyu","year":"2024","unstructured":"Lyu, L. et al. Growth differentiation factor-15 predicts all-cause death and major adverse cardiovascular events in patients with coronary heart disease: a prospective cohort study. J. Thromb. Thrombolysis. 57(7), 1109\u20131121 (2024).","journal-title":"J. Thromb. Thrombolysis."},{"key":"27988_CR11","doi-asserted-by":"crossref","unstructured":"Huseb\u00f8, G.R., Gr\u00f8nseth, R., Lerner, L., Gyuris, J., Hardie, J.A., Bakke, P.S. et al. Growth differentiation factor-15 is a predictor of important disease outcomes in patients with COPD. Eur. Respir. J. 49(3). https:\/\/pubmed.ncbi.nlm.nih.gov\/28298399\/. (2017).","DOI":"10.1183\/13993003.01298-2016"},{"key":"27988_CR12","doi-asserted-by":"crossref","unstructured":"Sivapalan, P., Lapperre, T.S., Janner, J., Laub, R.R., Moberg, M., Bech, C.S. et al. Eosinophil-guided corticosteroid therapy in patients admitted to hospital with COPD exacerbation (CORTICO-COP): a multicentre, randomised, controlled, open-label, non-inferiority trial. Lancet Respir. Med. 7(8):699\u2013709. https:\/\/www.thelancet.com\/action\/showFullText?pii=S2213260019301766. (2019).","DOI":"10.1016\/S2213-2600(19)30176-6"},{"issue":"5","key":"27988_CR13","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1161\/CIRCHEARTFAILURE.114.001185","volume":"7","author":"FP Brouwers","year":"2014","unstructured":"Brouwers, F. P. et al. Clinical risk stratification optimizes value of biomarkers to predict new-onset heart failure in a community-based cohort. Circ. Heart Fail. 7(5), 723\u2013731 (2014).","journal-title":"Circ. Heart Fail."},{"key":"27988_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4757-3294-8","volume-title":"Modeling Survival Data: Extending the Cox Model","author":"TM Therneau","year":"2000","unstructured":"Therneau, T. M. & Grambsch, P. M. Modeling Survival Data: Extending the Cox Model (Springer New York, 2000)."},{"key":"27988_CR15","unstructured":"Therneau, T.M. Survival analysis [R package survival version 3.8\u20133]. CRAN: contributed packages. https:\/\/CRAN.R-project.org\/package=survival. (2024)."},{"key":"27988_CR16","unstructured":"Sjoberg, D.D., Baillie, M., Fruechtenicht, C., Haesendonckx, S., Treis, T. Flexible time-to-event figures [R package ggsurvfit version 1.1.0]. CRAN: contributed packages. https:\/\/CRAN.R-project.org\/package=ggsurvfit. (2024)."},{"key":"27988_CR17","unstructured":"timeROC: time-dependent ROC curve and AUC for censored survival data. CRAN: contributed packages. https:\/\/CRAN.R-project.org\/package=timeROC. (2012)."},{"key":"27988_CR18","doi-asserted-by":"crossref","unstructured":"Verhamme, F.M., Freeman, C.M., Brusselle, G.G., Bracke, K.R., Curtis J.L. GDF-15 in pulmonary and critical care medicine. Am. J. Respir. Cell Mol. Biol. 60(6):621\u20138. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6543753\/. (2019).","DOI":"10.1165\/rcmb.2018-0379TR"},{"key":"27988_CR19","doi-asserted-by":"crossref","unstructured":"Schwarz, A., Kinscherf, R., Bonaterra, G.A. Role of the stress- and inflammation-induced cytokine GDF-15 in cardiovascular diseases: from basic research to clinical relevance.\u00a0 Rev. Cardiovasc. Med. 24, 2023.","DOI":"10.31083\/j.rcm2403081"},{"key":"27988_CR20","doi-asserted-by":"crossref","unstructured":"Lv, Z., Liang, G., Cheng, M. Predictive value of GDF-15 and sST2 for pulmonary hypertension in acute exacerbation of chronic obstructive pulmonary disease. Int. J. Chron. Obstruct Pulmon. Dis. 18:2431. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10637188\/. (2023).","DOI":"10.2147\/COPD.S429334"},{"key":"27988_CR21","doi-asserted-by":"crossref","unstructured":"Teng, Y.H.F., Aquino, R.S., Park, P.W. Molecular functions of syndecan-1 in disease. Matrix Biol. 31(1):3. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3568394\/. (2011).","DOI":"10.1016\/j.matbio.2011.10.001"},{"key":"27988_CR22","doi-asserted-by":"crossref","unstructured":"Sun, T., Wang, Y., Wu, X., Cai, Y., Zhai, T., Zhan, Q. prognostic value of syndecan-1 in the prediction of sepsis-related complications and mortality: a meta-analysis. Front. Public Health. 10:870065. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9035829\/. (2022).","DOI":"10.3389\/fpubh.2022.870065"},{"key":"27988_CR23","unstructured":"Kallis, C., Kaura, A., Samuel, N.A., Mulla, A., Glampson, B., O\u2019gallagher, K. et al. The relationship between cardiac troponin in people hospitalised for exacerbation of COPD and major adverse cardiac events (MACE) and COPD readmissions. Int. J. Chron. Obstruct Pulmon. Dis. 18: 2405\u201316. https:\/\/pubmed.ncbi.nlm.nih.gov\/37955026\/. (2023)."},{"key":"27988_CR24","doi-asserted-by":"crossref","unstructured":"Li, N., Chen, R., Li, J., Zhao, X., Wang, Y., Zhou, J. et al. Prognostic significance of serial N-terminal pro-B-type natriuretic peptide levels in patients with acute myocardial infarction: A prospective study. Am Heart J. 262:90\u20139. https:\/\/pubmed.ncbi.nlm.nih.gov\/37116605\/. (2023).","DOI":"10.1016\/j.ahj.2023.04.015"},{"key":"27988_CR25","doi-asserted-by":"crossref","unstructured":"Zhang, L.J., Li, N., Li, Y., Zeng, X.T., Liu, M.Y. Cardiac biomarkers predicting MACE in patients undergoing noncardiac surgery: a meta-analysis. Front Physiol. 9:1923. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6346145\/. (2019).","DOI":"10.3389\/fphys.2018.01923"},{"key":"27988_CR26","doi-asserted-by":"crossref","unstructured":"Davies, E., Mitford.,Buckley, B.J.R.,Austin, P.,Lip, G.Y.H.,Rao, A. et al. Aalborg universitet cardiac biomarkers predict major adverse cardiac events (MACE) in incident haemodialysis patients: results from a global federated database cardiac biomarkers predict major adverse cardiac events (MACE) in incident haemodialysis patients: results from a global federated database. 13:367. https:\/\/creativecommons.org\/licenses\/by\/4.0\/. (2025).","DOI":"10.3390\/biomedicines13020367"},{"issue":"1","key":"27988_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12890-017-0458-7","volume":"17","author":"P Sivapalan","year":"2017","unstructured":"Sivapalan, P. et al. A multi-center randomized, controlled, open-label trial evaluating the effects of eosinophil-guided corticosteroid-sparing therapy in hospitalised patients with COPD exacerbations - The CORTICO steroid reduction in COPD (CORTICO-COP) study protocol. BMC Pulm. Med. 17(1), 1\u20137. https:\/\/doi.org\/10.1186\/s12890-017-0458-7 (2017).","journal-title":"BMC Pulm. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27988-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27988-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27988-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T10:52:51Z","timestamp":1770720771000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27988-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["27988"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-27988-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,7]]},"assertion":[{"value":"28 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this Article was revised: In the original version of this Article, the author Tor Biering-S\u00f8rensen was incorrectly indexed. The original Article has been corrected.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"T.B-S. reports receiving research grants from Sanofi Pasteur and GE Healthcare, is a Steering Committee member of the Amgen financed GALACTIC-HF trial, on advisory boards for Sanofi Pasteur and Amgen, and speaker honorariums from Novartis and Sanofi Pasteur. J.V. reports personal fees from GlaxoSmithKline, Chiesi Pharmaceuticals, Boehringer-Ingelheim, Novartis, and AstraZeneca; and is supported by the National Institute of Health Research Manchester Biomedical Research Centre (Manchester, UK). The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results. All other authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"898"}}